0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Journal Articles

in Psychopharmacology

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders:  A Report of 2 Meta-analyses
Annelieke M. Roest, PhD; Peter de Jonge, PhD; Craig D. Williams, PharmD; et al.
JAMA
From the JAMA Network  | 
Surveillance of Adverse Psychiatric Medication Events
Mark Olfson, MD, MPH
JAMA Psychiatry
Original Investigation  | 
Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia:  Number Needed to Harm
Donovan T. Maust, MD, MS; Hyungjin Myra Kim, ScD; Lisa S. Seyfried, MD, MS; et al.
JAMA Neurology
Viewpoint  | 
Rationale for the Evaluation of Fluoxetine in the Treatment of Enterovirus D68-Associated Acute Flaccid Myelitis
Kenneth L. Tyler, MD